Unusual intercalation of acridin-9-ylthiourea into the 5′-GA/TC DNA base step from the minor groove:: implications for the covalent DNA adduct profile of a novel platinum-intercalator conjugate

被引:46
作者
Baruah, H [1 ]
Bierbach, U [1 ]
机构
[1] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA
关键词
D O I
10.1093/nar/gkg465
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The binding of the novel cytotoxic acridine derivative, 1-[2-(acridin-9-ylamino)ethyl]-1,3-dimethylthiourea (ACRAMTU) to various self-complementary oligonucleotide duplexes has been studied by combined high-resolution NMR spectroscopy/restrained molecular dynamics and equilibrium binding assays to establish the sequence and groove specificity of intercalation. The binding mode in the sequences d(GGACGTCC)(2) and d(GGAGCTCC)(2) was deduced from chemical shift changes and intermolecular NOEs between the ligand and the oligonucleotides. ACRAMTU intercalated into the 5'-CG/CG and 5'-GA/TC base steps, and penetration of the duplexes occurred from the minor groove. Intercalation of ACRAMTU in d(GGTACC)(2) occurs at the central TA/TA step, based on the absence of the internucleotide A4H8-T3H1' and A4H8-T3H3' cross-peaks in the 1:1 complex of this sequence. An energy- minimized AMBER model of the 1:2 complex, [d(GGAGCTCC)(2)(ACRAMTU)(2)], was generated, which was based on restricted molecular dynamics/ mechanics calculations using 108 NOE distance restraints (including 11 DNA-drug distances per ligand). Equilibrium dialysis experiments were performed using octamers containing various base steps present in the 'NMR sequences'. The highest affinity for ACRAMTU was observed in d(TATAT ATA)(2), followed by d(CGCGCGCG)(2) and d(GAG ATCTC)(2). The binding levels for CG/CG and GA/TC were virtually the same. The unusual tolerance of the GA/TC intercalation site and the pronounced groove specificity of ACRAMTU play a significant role in the molecular recognition between the corresponding platinum conjugate, Pt-ACRAMTU, and DNA.
引用
收藏
页码:4138 / 4146
页数:9
相关论文
共 37 条
[1]   Crystal structure of 9-amino-N-[2-(4-morpholinyl)ethyl]-4-acridinecarboxamide bound to d(CGTACG)2:: implications for structure-activity relationships of acridinecarboxamide topoisomerase poisons [J].
Adams, A ;
Guss, JM ;
Denny, WA ;
Wakelin, LPG .
NUCLEIC ACIDS RESEARCH, 2002, 30 (03) :719-725
[2]   Crystal structure of the topoisomerase II poison 9-amino-[N-(2-dimethylamino)ethyl]acridine-4-carboxamide bound to the DNA hexanucleotide d(CGTACG)2 [J].
Adams, A ;
Guss, JM ;
Collyer, CA ;
Denny, WA ;
Wakelin, LPG .
BIOCHEMISTRY, 1999, 38 (29) :9221-9233
[3]  
[Anonymous], 2002, NUCL ACID STRUCTURE
[4]  
BAGULEY BC, 1991, ANTI-CANCER DRUG DES, V6, P1
[5]   Thermally inert metal ammines as light-inducible DNA-Targeted agents. Synthesis, photochemistry, and photobiology of a prototypical Rhodium(III)-intercalator conjugate [J].
Barry, CG ;
Turney, EC ;
Day, CS ;
Saluta, G ;
Kucera, GL ;
Bierbach, U .
INORGANIC CHEMISTRY, 2002, 41 (26) :7159-7169
[6]  
BARRY CG, 2002, 54 SE REG M AM CHEM
[7]   Mechanism of action of non-cisplatin type DNA-targeted platinum anticancer agents: DNA interactions of novel acridinylthioureas and their platinum conjugates [J].
Baruah, H ;
Rector, CL ;
Monnier, SM ;
Bierbach, U .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (02) :191-200
[8]   Molecular recognition between a new pentacyclic acridinium salt and DNA sequences investigated by optical spectroscopic techniques, proton nuclear magnetic resonance spectroscopy, and molecular modeling [J].
Bostock-Smith, CE ;
Giménez-Arnau, E ;
Missailidis, S ;
Laughton, CA ;
Stevens, MFG ;
Searle, MS .
BIOCHEMISTRY, 1999, 38 (21) :6723-6731
[9]   Mechanism of cytotoxicity of N-[2-(dimethylamino)ethyl] acridine-4-cariboxamide and of its 7-chloro derivative:: the roles of topoisomerases I and II [J].
Bridewell, DJA ;
Finlay, GJ ;
Baguley, BC .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (04) :302-308
[10]   Cytotoxic acridinylthiourea and its platinum conjugate produce enzyme-mediated DNA strand breaks [J].
Brow, JM ;
Pleatman, CR ;
Bierbach, U .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (20) :2953-2955